S&P 500   3,150.29 (+1.05%)
DOW   28,024.05 (+1.25%)
QQQ   205.03 (+1.28%)
AAPL   270.78 (+1.96%)
FB   200.93 (+0.79%)
MSFT   151.37 (+0.96%)
GOOGL   1,340.74 (+1.65%)
AMZN   1,752.17 (-0.48%)
CGC   18.66 (+0.32%)
NVDA   211.65 (+1.06%)
MU   48.02 (+3.00%)
BABA   201.66 (+0.83%)
GE   10.98 (+1.76%)
TSLA   337.34 (+1.29%)
T   38.29 (+0.26%)
AMD   39.59 (-0.25%)
NFLX   306.25 (+0.63%)
DIS   147.94 (+0.34%)
S&P 500   3,150.29 (+1.05%)
DOW   28,024.05 (+1.25%)
QQQ   205.03 (+1.28%)
AAPL   270.78 (+1.96%)
FB   200.93 (+0.79%)
MSFT   151.37 (+0.96%)
GOOGL   1,340.74 (+1.65%)
AMZN   1,752.17 (-0.48%)
CGC   18.66 (+0.32%)
NVDA   211.65 (+1.06%)
MU   48.02 (+3.00%)
BABA   201.66 (+0.83%)
GE   10.98 (+1.76%)
TSLA   337.34 (+1.29%)
T   38.29 (+0.26%)
AMD   39.59 (-0.25%)
NFLX   306.25 (+0.63%)
DIS   147.94 (+0.34%)
S&P 500   3,150.29 (+1.05%)
DOW   28,024.05 (+1.25%)
QQQ   205.03 (+1.28%)
AAPL   270.78 (+1.96%)
FB   200.93 (+0.79%)
MSFT   151.37 (+0.96%)
GOOGL   1,340.74 (+1.65%)
AMZN   1,752.17 (-0.48%)
CGC   18.66 (+0.32%)
NVDA   211.65 (+1.06%)
MU   48.02 (+3.00%)
BABA   201.66 (+0.83%)
GE   10.98 (+1.76%)
TSLA   337.34 (+1.29%)
T   38.29 (+0.26%)
AMD   39.59 (-0.25%)
NFLX   306.25 (+0.63%)
DIS   147.94 (+0.34%)
S&P 500   3,150.29 (+1.05%)
DOW   28,024.05 (+1.25%)
QQQ   205.03 (+1.28%)
AAPL   270.78 (+1.96%)
FB   200.93 (+0.79%)
MSFT   151.37 (+0.96%)
GOOGL   1,340.74 (+1.65%)
AMZN   1,752.17 (-0.48%)
CGC   18.66 (+0.32%)
NVDA   211.65 (+1.06%)
MU   48.02 (+3.00%)
BABA   201.66 (+0.83%)
GE   10.98 (+1.76%)
TSLA   337.34 (+1.29%)
T   38.29 (+0.26%)
AMD   39.59 (-0.25%)
NFLX   306.25 (+0.63%)
DIS   147.94 (+0.34%)
Log in

NASDAQ:TELA - TELA Bio Stock Price, Forecast & News

$12.50
+0.43 (+3.56 %)
(As of 12/6/2019 01:27 PM ET)
Today's Range
$11.75
Now: $12.50
$12.50
50-Day Range N/A
52-Week Range
$10.78
Now: $12.50
$15.05
Volume1,258 shs
Average Volume85,117 shs
Market Capitalization$137.58 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. It offers reinforced tissue matrix products for a variety of reconstruction procedures, including hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. The company provides a portfolio of OviTex Reinforced Tissue Matrix or OviTex products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix or OviTex PRS products to address the unmet needs in plastic and reconstructive surgery. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TELA
CUSIPN/A
CIKN/A
Phone484-320-2930

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.27 million

Profitability

Miscellaneous

Employees78
Market Cap$137.58 million
Next Earnings DateN/A
OptionableNot Optionable

Receive TELA News and Ratings via Email

Sign-up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.


TELA Bio (NASDAQ:TELA) Frequently Asked Questions

What is TELA Bio's stock symbol?

TELA Bio trades on the NASDAQ under the ticker symbol "TELA."

What price target have analysts set for TELA?

4 brokers have issued 12 month price objectives for TELA Bio's stock. Their forecasts range from $17.00 to $23.00. On average, they anticipate TELA Bio's stock price to reach $20.25 in the next twelve months. This suggests a possible upside of 62.0% from the stock's current price. View Analyst Price Targets for TELA Bio.

What is the consensus analysts' recommendation for TELA Bio?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TELA Bio in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for TELA Bio.

Has TELA Bio been receiving favorable news coverage?

News stories about TELA stock have been trending neutral on Friday, according to InfoTrie. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. TELA Bio earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for TELA Bio.

Who are some of TELA Bio's key competitors?

What other stocks do shareholders of TELA Bio own?

Who are TELA Bio's key executives?

TELA Bio's management team includes the folowing people:
  • Mr. Antony Koblish, Pres, CEO & Director (Age 53)
  • Dr. Maarten Persenaire, Co-Founder & Chief Medical Officer (Age 62)
  • Ms. Nora E. Brennan, Chief Financial Officer (Age 51)
  • Mr. Michael Leonard, VP of Operations
  • Dr. E. Skott Greenhalgh Ph.D., Chief Technology Officer (Age 52)

When did TELA Bio IPO?

(TELA) raised $60 million in an initial public offering (IPO) on Friday, November 8th 2019. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. Jefferies and Piper Jaffray served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

When does TELA Bio's quiet period expire?

TELA Bio's quiet period expires on Wednesday, December 18th. TELA Bio had issued 4,000,000 shares in its public offering on November 8th. The total size of the offering was $52,000,000 based on an initial share price of $13.00. During TELA Bio's quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of TELA Bio?

Shares of TELA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is TELA Bio's stock price today?

One share of TELA stock can currently be purchased for approximately $12.50.

How big of a company is TELA Bio?

TELA Bio has a market capitalization of $137.58 million and generates $8.27 million in revenue each year. TELA Bio employs 78 workers across the globe.View Additional Information About TELA Bio.

What is TELA Bio's official website?

The official website for TELA Bio is http://www.telabio.com/.

How can I contact TELA Bio?

TELA Bio's mailing address is 1 GREAT VALLEY PARKWAY SUITE 24, MALVERN PA, 19355. The company can be reached via phone at 484-320-2930 or via email at [email protected]


MarketBeat Community Rating for TELA Bio (NASDAQ TELA)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  8 (Vote Underperform)
Total Votes:  20
MarketBeat's community ratings are surveys of what our community members think about TELA Bio and other stocks. Vote "Outperform" if you believe TELA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TELA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel